Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Income from Continuing Operations: 2018-2020

Historic Income from Continuing Operations for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $552.7 million.

  • Genmab A's Income from Continuing Operations rose 362.62% to $169.09 in Q2 2021 from the same period last year, while for Jun 2021 it was $356.29, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $552.7 million for FY2020, which is 145.38% up from last year.
  • According to the latest figures from FY2020, Genmab A's Income from Continuing Operations is $552.7 million, which was up 145.38% from $225.3 million recorded in FY2019.
  • Genmab A's Income from Continuing Operations' 5-year high stood at $552.7 million during FY2020, with a 5-year trough of $162.7 million in FY2018.
  • For the 3-year period, Genmab A's Income from Continuing Operations averaged around $313.6 million, with its median value being $225.3 million (2019).
  • Data for Genmab A's Income from Continuing Operations shows a peak YoY skyrocketed of 145.38% (in 2020) over the last 5 years.
  • Over the past 3 years, Genmab A's Income from Continuing Operations (Yearly) stood at $162.7 million in 2018, then soared by 38.41% to $225.3 million in 2019, then skyrocketed by 145.38% to $552.7 million in 2020.